Not Signed In - New Drug Shown To Reduce Gastric Ulcers In At-risk Patients Using Long-term NSAIDS
Sun, 26 Mar 2006 02:00 PM EST
... March 2006, Wilmington, DE. Results from two clinical trials, to be published in the April 2006 edition of the American Journal of Gastroenterology, indicate that NEXIUM® (esomeprazole magnesium) can reduce the incidence of gastric (stomach) ulcers in patients at risk of developing gastric ulcers and who regularly take either non-selective nonsteroidal anti-inflammatory drugs (NSAIDs) or COX-2-selective NSAIDs... click link for more info. ...
Related Topics
- Long Term Care
- Gastric Ulcer
- NSAIDs and Peptic Ulcers
- Acute Care
- Weight Loss Surgery
- Smoking Cessation and Continued Risk in Cancer Patients
- Risk Factors
- Long Term Care/ltc
- Vegetative state (long-term coma)
- Chronic (long-term) kidney failure
- Long-term incontinence or urinary retention
- Complications due to long-term catheter use
- Inhalants
- Weak bones (osteomalacia) and osteoporosis (due to very long-term cholestasis)
- Nursing Home Care
- Stroke, if clots break off and travel to the brain (drugs that thin the blood such as heparin and warfarin can reduce the risk)
- Ulcers
- Disabilities
- Security Risk Assessment
- Stomach Cancer
email this page
print this page
bookmark this page
feedback on this page
